Novo Nordisk A/S
DEEURNovo Nordisk A/S (US:NONOF) — Biotechnology: Pharmaceutical Preparations. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 3. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
- Novo Nordisk A/S — NOVO-B · CO DK Registreerimisnumber teadmata
Ettevõtte Kohta
- Veebileht
- novonordisk.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Peakontor
- BAGSVAERD DENMARK, Denmark
- Tegevjuht
- Maziar Mike Doustdar
- Töötajad
- 66 700
- Ringluses Olevad Aktsiad
- 3.34 mld
- Vabalt Kaubeldavad Aktsiad
- 3.17 mld
- Turukapitalisatsioon
- 150.93 mld EUR
- Siseringi Isikud
- 5.27%
- Institutsionaalsed Investorid
- 33.78%
- Tegevusala (SIC)
- Pharmaceutical Preparations
- Õiguslik Vorm
- ZRPO
- ISIN
- DK0060534915
- LEI
- 549300DAQ1CVT6CXN342
- Väljamaksesuhe
- 50.5%
- FCF
- 59.0 mld DKK
- Väljamakse / FCF
- 88%
- Võlg
- 143 mld DKK2.0 a FCF
- Dividendistaaž
- 24 a
- Kasum, FCF ja dividendid makstud — 12 kuu jooksul kuni 31.12.2025 (ettevõtte viimane raport).
Kirjeldus
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. The company has a collaboration with Anthropic accelerate the development of new medicines and advance AI-driven software development. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. It has a strategic collaboration with Orbis Medicines to discover and develop oral macrocycle therapeutics for cardiometabolic diseases. The company was formerly known as Novo Industri A/S and changed its name to Novo Nordisk A/S in April 1989. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Dividendid
Novo Nordisk A/S (NONOF) maksab dividende kaks korda aastas. Aastas (12 kuud kuni viimase teatatud maksega): 11.7 DKK aktsia kohta (maksed: 2). Makseajaloo põhjal oodatakse järgmist ex-dividendi kuupäeva umbes 15.02.2027. Katkematu dividendiajalugu: 24 aastat.
| Ex-Kuupäev | Väljamakse | Summa | % | Tüüp | Tikker |
|---|---|---|---|---|---|
| 2026-08-17 | 2026-08-18 | 3.7500 DKK | 1.2/3.9 % | poolaastane | US:NONOF |
| 2026-03-30 | 2026-03-31 | 7.9500 DKK | 3.4/5.0 % | poolaastane | US:NONOF |
| 2025-08-18 | 2025-08-19 | 3.7500 DKK | 1.1/3.4 % | poolaastane | US:NONOF |
| 2025-03-31 | 2025-04-01 | 7.9000 DKK | 1.7/2.5 % | poolaastane | US:NONOF |
| 2024-08-16 | 2024-08-19 | 3.5000 DKK | 1.4/3.8 % | poolaastane | US:NONOF |
| 2024-03-22 | 2024-03-26 | 6.4000 DKK | 2.5/≈4.9 % | poolaastane | US:NONOF |
Suurimad Omanikud
| Omanik | Osalus | Aktsiad | Aruande Kuupäev |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.38% | 46.88 mln | 2026-07-31 |
| EuroPacific Growth Fund-… | 1.07% | 36.2 mln | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.92% | 31.13 mln | 2026-06-30 |
| Capital World Growth & I… | 0.77% | 26.02 mln | 2026-06-30 |
| iShares Trust-iShares Co… | 0.71% | 24.13 mln | 2026-08-31 |
| Income Fund of America | 0.52% | 17.78 mln | 2026-07-31 |
| Dodge & Cox Funds-Dodge… | 0.39% | 13.1 mln | 2026-06-30 |
| Fidelity Concord Street… | 0.37% | 12.52 mln | 2026-07-31 |
| iShares Trust-iShares MS… | 0.34% | 11.48 mln | 2026-08-31 |
| Capital Income Builder | 0.3% | 10.32 mln | 2026-07-31 |
| Cygnus Capital Advisors,… | 0% | 78 800 | 2026-06-30 |
| Generali Investments Cee… | 0% | 27 399 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 24 410 | 2026-06-30 |
| Atlas Capital Advisors I… | 0% | 5 218 | 2026-06-30 |
| Novo Holdings | — | — | — |
| Novo Nordisk Foundation | — | — | — |
Logi Sisse Google